Chinook therapeutics revenue
WebAug 8, 2024 · Revenue – Revenue for the quarter and six months ended June 30, 2024 was $0.4 million and $3.1 million, respectively, compared to less than $0.1 million and $0.4 million for the same periods in ... WebFeb 27, 2024 · Chinook Therapeutics (KDNY) came out with a quarterly loss of $0.90 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compare...
Chinook therapeutics revenue
Did you know?
WebChinook Therapeutics revenue from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of … WebChinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases. Changing the Course of Kidney Care™ Read More
WebFeb 25, 2024 · The revenue for CHK-336 is expected to reach an annual total of $24 mn by 2035 globally based off GlobalData’s Expiry Model. The drug’s revenue forecasts along … WebDec 31, 2024 · Revenue – Total revenue increased by $50.4 million and $50.8 million for the quarter and year ended December 31, 2024, respectively, compared to the same periods in 2024. ... CHINOOK THERAPEUTICS, INC. Consolidated Statements of …
WebFeb 27, 2024 · The higher revenue amounts in 2024 were primarily due to $41.2 million non-cash revenue recognized under Chinook’s license agreement with SanReno Therapeutics and a $10.0 million milestone ...
WebFeb 26, 2024 · Based on Chinook Therapeutics’ latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $2.5 million and a GAAP net loss of $55.98 million.
WebFeb 25, 2024 · Chinook is headquartered in Berkeley, California, the US. The company reported revenues of (US Dollars) US$51.6 million for the fiscal year ended December 2024 (FY2024), compared to a revenue of US$0.8 million in FY2024. The operating loss of the company was US$99 million in FY2024, compared to an operating loss of US$83.9 … bitterfeld wasserstoffWebFeb 27, 2024 · Chinook Therapeutics GAAP EPS of -$0.90 misses by $0.11, revenue of $0.51M beats by $0.41M Feb. 27, 2024 4:05 PM ET Chinook Therapeutics, Inc. … datashop cboeWebApr 13, 2024 · Posted by Defense World Staff on Apr 13th, 2024. Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating) gapped down before the market opened on … datashield north platte neWebAug 8, 2024 · Chinook Therapeutics, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, provided a business update and reported financial results for the quarter and six months ended June 30, 2024. ... Revenue – Revenue for the quarter and six months ended … bitterfeld walther rathenau strWebApr 13, 2024 · Posted by Defense World Staff on Apr 13th, 2024. Chinook Therapeutics, Inc. ( NASDAQ:KDNY – Get Rating) gapped down before the market opened on Tuesday . The stock had previously closed at $21. ... bitterfeld walther rathenau str. 1WebChinook Therapeutics Revenue is currently at 51.62 K. Revenue is income that a firm generates from business activities such us rendering services or selling goods to … bitterfeld tourist infoWeb2 days ago · A recent report from the Kaiser Family Foundation estimated that nonprofit hospitals were exempt from paying nearly $28 billion in taxes in 2024, up 41% from their about $20 billion in tax breaks ... bitterfeld rathaus